AlzeCure Pharma to Present at Swiss Nordic Bio 2026 in Zurich

STOCKHOLM, SE / ACCESS Newswire / September 22, 2026 / AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6), which develops small-molecule drug candidates for CNS diseases with a focus on Alzheimer's disease and pain, today announced that the company …